Drug class in one race
GLP-1/GIP receptor (dual) drugs for Atherosclerotic Cardiovascular Disease
2 tracked GLP-1/GIP receptor (dual) drugs in the Atherosclerotic Cardiovascular Disease race. The class explanation lives on the GLP-1/GIP receptor (dual) page; the full indication pipeline across every mechanism is on the Atherosclerotic Cardiovascular Disease page.
1 Phase 31 preclinical / unstaged